Genentech at TPD Summit 2026

Oct 26–29, 2026 Boston, MA ~300 attendees Website

Genentech takes part in 3 sessions at TPD Summit 2026 in Boston. Its sessions cover the safety risks particular to targeted degradation and how better informatics and predictive models can guide the design of next-generation degraders.

OrganizationTPD Summit 2026 Attendance
Genentech
South San Francisco, CA
gene.com
Large pharma
Biotechnology company and Roche Group member that discovers, develops and markets medicines.
Talk
Tue Oct 27
12:30pm
New Frontiers, New Risks: Mapping the Safety Complexities of Targeted Degradation
Track B: Pre-Clinical Development
Talk
Thu Oct 29
9:30am
Optimizing the Next Generation Degraders with Better Informatics, Descriptors & Predictive Modeling
Latest Tools & Technologies Track
AI & computational design
Panel
Thu Oct 29
10:00am
Harnessing AI & Computational Modelling to Optimize Design, Specificity & Efficacy of Induced Proximity Molecules to Support the Development of Tolerable, Selective Therapies
Latest Tools & Technologies Track · with Orionis Biosciences, Eli Lilly, Protai
AI & computational design

Explore the full TPD Summit 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full TPD Summit 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Genentech

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the TPD & Induced Proximity Summit or its organizers. Submit a correction